Yannik Haven

Dr. Yannik Haven

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Nessr Abu RachedNessr Abu Rached
Nessr Abu Rached
Johannes W. DietrichJohannes W. Dietrich
Johannes W. Dietrich
LOLennart Ocker-Serger
Lennart Ocker-Serger
ESEggert Stockfleth
Eggert Stockfleth
YHYannik Haven
Yannik Haven
FBFalk G. Bechara
Falk G. Bechara
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease often associated with metabolic disorders such as diabetes mellitus. Recent research suggests a link between systemic inflammation and insulin–glucose dysregulation in HS. This study investigates the relationship between insulin–glucose homeostasis, diabetes mellitus and the haptoglobin concentration in HS patients. Methods: We assessed 95 HS patients and 49 controls using validated fasting-based function tests, including the Structural Parameter Inference Approach (SPINA), Homeostasis Model Assessment (HOMA) and Quantitative Insulin Sensitivity Check Index (QUICKI). Results: The HS patients had a significantly higher fasting insulin concentration (97.2 vs. 69.0 pmol/L, p = 0.035), increased insulin resistance (HOMA-IR: 3.47 vs. 2.57, p = 0.016) and impaired insulin sensitivity (SPINA-GR: 1.34 vs. 1.76 mol/s, p = 0.017). In diabetes, the insulin sensitivity was more strongly reduced (SPINA-GR: 0.61 vs. 1.41 mol/s, p = 0.0057) and the insulin resistance increased (HOMA-IR: 7.3 vs. 3.2, p = 0.017). Higher haptoglobin concentrations were accompanied by worse glycaemic control, demonstrating a significantly elevated fasting glucose (5.77 vs. 5.11 mmol/L, p = 0.043) concentration and HbA1c (5.7% vs. 5.4%, p = 0.0081) fraction. Conclusions: Our findings suggest that chronic inflammation in HS contributes to metabolic dysregulation, worsening insulin resistance and glycaemic control, particularly in those with elevated haptoglobin or diabetes.

19 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
Nessr Abu RachedNessr Abu Rached
Nessr Abu Rached
RKRiina Käpynen
Riina Käpynen
MDMartin Doerler
Martin Doerler
LOLennart Ocker-Serger
Lennart Ocker-Serger
CFCarolin Frost
Carolin Frost
FBFalk G. Bechara
Falk G. Bechara
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with significant morbidity. Although cutaneous squamous cell carcinoma (cSCC) is a rare complication, it has serious consequences, particularly when associated with high-risk human papillomavirus (HPV) infections. This study examines two cases of HPV-16-induced cSCC in patients with long-standing HS and explores the potential role of HPV vaccination in preventing such malignancies. Methods and results: We report on two male patients with severe HS (Hurley stage III) and cutaneous squamous cell carcinoma with positive detection of HPV DNA in the tumour tissue. Conclusions: HPV vaccination may offer a preventive approach to cSCC in HS patients by reducing high-risk HPV infections. Incorporating vaccination into the management of HS, particularly in high-risk individuals, could potentially reduce the incidence of malignant transformation and improve long-term outcomes. Further research is warranted to validate these findings and refine prevention strategies.

2 May 2025 in Life
Verified
Journal Article
Open access
PDF file
Nessr Abu RachedNessr Abu Rached
Nessr Abu Rached
HTHanna Telkemeyer
Hanna Telkemeyer
MSMarina Skrygan
Marina Skrygan
MDMartin Doerler
Martin Doerler
YHYannik Haven
Yannik Haven
FBFalk G. Bechara
Falk G. Bechara
Background: Meta-inflammation is a hallmark of hidradenitis suppurativa (HS). Research on meta-inflammation in HS is growing, but there is still no research on haptoglobin as an inflammatory protein in lesional HS skin. This study examines the relationship between haptoglobin expression in HS skin lesions and clinical parameters. Methods: An examination was performed on 44 skin samples from HS patients and 10 healthy skin samples. Clinical parameters were then compared with haptoglobin expression. Results: Median haptoglobin expression was significantly higher in the Hurley stage III lesions compared with milder stages (H-score: 37.6 versus 17.1, p = 0.028). High haptoglobin expression (≥30.8% positive cells) was associated with advanced disease (Hurley stage III: 80% versus 41.7%, p = 0.01), active smoking (80% versus 50%, p = 0.039), increased pain (visual analogue scale: 5 versus 1.5, p = 0.03), and a higher prevalence of diabetes (35% versus 8.3%, p = 0.029) and hypertension (55% versus 25%, p = 0.042). No significant associations were found with the BMI, disease duration, or CRP levels. Conclusions: High haptoglobin expression (positive cells ≥ 30.8%) in a skin lesion is associated with higher HS severity, active smoking, more pain and the comorbidities of diabetes mellitus and arterial hypertension in HS patients.

25 August 2025 in Dermatopathology
Verified
Journal Article
Open access
PDF file
Nessr Abu RachedNessr Abu Rached
Nessr Abu Rached
SBStefanie Bruckmüller
Stefanie Bruckmüller
MDMartin Doerler
Martin Doerler
HTHanna Telkemeyer
Hanna Telkemeyer
LOLennart Ocker-Serger
Lennart Ocker-Serger
FBFalk G. Bechara
Falk G. Bechara
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease with a complex immune response. Given the considerable heterogeneity of the clinical phenotype of HS, this study aimed to analyse the immunohistochemical pattern of interstitial inflammation. Methods: Immunohistochemical analysis was performed on skin samples from 49 patients with HS. The immunohistochemical markers CD3, CD4 and CD8 for T-cells, CD20 for B-cells, CD138 for plasma cells and CD30, CD56, Bcl-2 and Bcl-6 were stained on lesional skin. Results: The analysis of immune cell dominance in patients with HS revealed that 33.3% of the cohort exhibited B-cell dominance, defined as a ratio of the sum of CD20+ and CD138+ cells to CD3+ cells greater than 1, while the majority (66.7%) demonstrated T-cell dominance, defined as a ratio of CD3+ cells to the sum of CD20+ and CD138+ cells greater than 1. B-cell-dominant HS is associated with a significantly elevated probability of mammary involvement (13.3% vs. 0%; p = 0.041). T-cell-dominant HS patients tended to demonstrate a higher mean tobacco consumption, but not significantly (20 vs. 5 tobacco pack-years; p = 0.06). CD4-dominant HS patients exhibited a significantly greater involvement of the mons pubis (62.5% vs. 28.6%, p = 0.023) compared to CD8-dominant patients, who demonstrated a significantly higher number of abscesses (p = 0.027). Conclusions: For the first time, we describe the clinical and immunohistochemical characteristics of T-cell- and B-cell-dominant HS. Although HS seems to be more dominated by T-cells, a B-cell dominance was found in 33% of cases.

21 May 2026
Verified
Book Chapter
Open access
MAMohamed Alhaskir
Mohamed Alhaskir
HHHannah Haven
Hannah Haven
MLMichael Langer
Michael Langer
TPTim Peters
Tim Peters
MHMiriam Hertwig
Miriam Hertwig
JBJonas Bienzeisler
Jonas Bienzeisler
The study presents a local large language model pipeline for automated feedback in pediatric simulation-based medical education. The system generates structured reports using the Liverpool Undergraduate Communication Assessment Scale. Four communication simulations were processed and evaluated against human feedback. The model generated structured reports with total scores (mean = 13.9 ± 1.2) comparable to human ratings (mean = 12.8 ± 2.9). Scenario-level analyses indicated variation in some cases but overall reliable performance across simulation runs. The pipeline demonstrated lower inter-rater variability (SD = 0.7–1.7) than human examiners (SD = 1.3–2.9), indicating greater internal consistency. The findings inform a forthcoming prospective evaluation.

22 October 2025 in Life
Verified
Journal Article
Open access
PDF file
YHYannik Haven
Yannik Haven
Nessr Abu RachedNessr Abu Rached
Nessr Abu Rached
CMCharlotte Michel
Charlotte Michel
DMDaniel Myszkowski
Daniel Myszkowski
LOLennart Ocker-Serger
Lennart Ocker-Serger
FBFalk G. Bechara
Falk G. Bechara
Background: Hidradenitis suppurativa (HS) is a chronic, relapsing inflammatory dermatosis with substantial quality-of-life impact. HS frequently co-exists with obesity and metabolic comorbidities. Cigarette smoking is highly prevalent and has been linked to heightened inflammatory activity and impaired wound healing. The role of cumulative tobacco exposure (packyears) in relation to metabolic comorbidities in HS is less well defined. We therefore investigated whether lifetime pack-years relate to laboratory parameters and the presence of comorbidities in HS. Methods: We conducted a retrospective, single-center study involving 131 patients with HS. We collected clinical data, including disease severity scores and quality of life indices, along with laboratory markers such as complete blood count and C-reactive protein. Smoking status and cumulative exposure (pack-years) were assessed based on patient history. To compare laboratory parameters between smoking subgroups, we used Mann–Whitney U tests. Additionally, we performed logistic regression analyses to evaluate the association between cumulative cigarette exposure and the presence of comorbidities. Results: Among the cohort, 63.4% were active smokers with a median of 15 pack-years. Smokers had significantly higher leukocyte, neutrophil, lymphocyte, monocyte, eosinophil, and basophil counts, indicating elevated systemic inflammation. Hematocrit, hemoglobin, mean corpuscular volume, and mean corpuscular hemoglobin were also significantly higher in smokers, while C-reactive protein levels did not differ notably between groups. Subgroup analysis revealed that patients with arterial hypertension, diabetes mellitus, and hypercholesterolemia had significantly more pack-years than those without these conditions. These comorbidities, components of metabolic syndrome, were strongly associated with higher lifetime tobacco exposure in HS patients. Conclusions: Smoking contributes not only to heightened inflammatory activity in HS but is also significantly associated with the presence of metabolic comorbidities. These findings underscore the importance of early interdisciplinary intervention and structured smoking cessation programs to improve outcomes in HS patients.